Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
- Status
- COMPLETED
- Phase
- PHASE1
Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S
- Status
- COMPLETED
- Phase
- N/A
Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE3
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates
- Status
- COMPLETED
- Phase
- PHASE1
Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings
- Status
- COMPLETED
- Phase
- N/A
Local Adaptation of Cost Effectiveness Model for Apixaban Atrial Fibrillation Indication - Venezuela
- Status
- COMPLETED
- Phase
- N/A
Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants
- Status
- COMPLETED
- Phase
- N/A
An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE3
Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2